Through pharmacologic and genetic approaches, we found that inhibition of DOT1L, a H3K79 methyltransferase, profoundly reduces viability of a subset of MM cell lines in vitro and inhibits growth of established MM xenografts in mice. This evidence concerns the gene DOT1L and Miyoshi myopathy.